# An Efficacy and Safety Study of Golimumab in Patients With Active Rheumatoid Arthritis Despite Methotrexate Therapy

> **NCT00264550** · PHASE3 · COMPLETED · sponsor: **Centocor, Inc.** · enrollment: 444 (actual)

## Conditions studied

- Rheumatoid Arthritis

## Interventions

- **DRUG:** Golimumab 100 mg
- **DRUG:** Golimumab 50 mg
- **DRUG:** Methotrexate
- **DRUG:** Placebo injection
- **DRUG:** Placebo capsules

## Key facts

- **NCT ID:** NCT00264550
- **Lead sponsor:** Centocor, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-12
- **Primary completion:** 2007-09
- **Final completion:** 2012-05
- **Target enrollment:** 444 (ACTUAL)
- **Last updated:** 2014-04-29

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00264550

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00264550, "An Efficacy and Safety Study of Golimumab in Patients With Active Rheumatoid Arthritis Despite Methotrexate Therapy". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00264550. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*